orsus labs limited
orsus labs limited Company Information
Company Number
12480125
Next Accounts
Sep 2025
Shareholders
amphora health ltd
Group Structure
View All
Industry
Physical well-being activities
Registered Address
riverbank house, 1 putney bridge approach, london, SW6 3JD
Website
-orsus labs limited Estimated Valuation
Pomanda estimates the enterprise value of ORSUS LABS LIMITED at £29.2k based on a Turnover of £51.2k and 0.57x industry multiple (adjusted for size and gross margin).
orsus labs limited Estimated Valuation
Pomanda estimates the enterprise value of ORSUS LABS LIMITED at £0 based on an EBITDA of £0 and a 3.69x industry multiple (adjusted for size and gross margin).
orsus labs limited Estimated Valuation
Pomanda estimates the enterprise value of ORSUS LABS LIMITED at £0 based on Net Assets of £-279.6k and 2.08x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Orsus Labs Limited Overview
Orsus Labs Limited is a live company located in london, SW6 3JD with a Companies House number of 12480125. It operates in the physical well-being activities sector, SIC Code 96040. Founded in February 2020, it's largest shareholder is amphora health ltd with a 100% stake. Orsus Labs Limited is a young, micro sized company, Pomanda has estimated its turnover at £51.2k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Orsus Labs Limited Health Check
Pomanda's financial health check has awarded Orsus Labs Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 4 areas for improvement. Company Health Check FAQs
1 Strong
2 Regular
4 Weak
Size
annual sales of £51.2k, make it smaller than the average company (£152.3k)
- Orsus Labs Limited
£152.3k - Industry AVG
Growth
3 year (CAGR) sales growth of -18%, show it is growing at a slower rate (8.5%)
- Orsus Labs Limited
8.5% - Industry AVG
Production
with a gross margin of 48.9%, this company has a higher cost of product (74%)
- Orsus Labs Limited
74% - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Orsus Labs Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (5)
- Orsus Labs Limited
5 - Industry AVG
Pay Structure
on an average salary of £19.9k, the company has an equivalent pay structure (£19.9k)
- Orsus Labs Limited
£19.9k - Industry AVG
Efficiency
resulting in sales per employee of £51.2k, this is equally as efficient (£44.9k)
- Orsus Labs Limited
£44.9k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Orsus Labs Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 3902 days, this is slower than average (64 days)
- Orsus Labs Limited
64 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Orsus Labs Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Orsus Labs Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Orsus Labs Limited
- - Industry AVG
ORSUS LABS LIMITED financials
Orsus Labs Limited's latest turnover from December 2023 is estimated at £51.2 thousand and the company has net assets of -£279.6 thousand. According to their latest financial statements, we estimate that Orsus Labs Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|
| Turnover | ||||
| Other Income Or Grants | ||||
| Cost Of Sales | ||||
| Gross Profit | ||||
| Admin Expenses | ||||
| Operating Profit | ||||
| Interest Payable | ||||
| Interest Receivable | ||||
| Pre-Tax Profit | ||||
| Tax | ||||
| Profit After Tax | ||||
| Dividends Paid | ||||
| Retained Profit | ||||
| Employee Costs | ||||
| Number Of Employees | 3 | 5 | 5 | |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|
| Tangible Assets | ||||
| Intangible Assets | ||||
| Investments & Other | ||||
| Debtors (Due After 1 year) | ||||
| Total Fixed Assets | ||||
| Stock & work in progress | 162,843 | |||
| Trade Debtors | 4,939 | 5,596 | ||
| Group Debtors | 97,925 | |||
| Misc Debtors | 882 | 31,103 | ||
| Cash | 3,263 | 25,629 | ||
| misc current assets | ||||
| total current assets | 4,939 | 102,070 | 225,171 | |
| total assets | 4,939 | 102,070 | 225,171 | |
| Bank overdraft | ||||
| Bank loan | ||||
| Trade Creditors | 279,553 | 284,492 | 1,602 | 2,788 |
| Group/Directors Accounts | 366,210 | 337,561 | ||
| other short term finances | ||||
| hp & lease commitments | ||||
| other current liabilities | 9,897 | 9,817 | ||
| total current liabilities | 279,553 | 284,492 | 377,709 | 350,166 |
| loans | ||||
| hp & lease commitments | ||||
| Accruals and Deferred Income | ||||
| other liabilities | ||||
| provisions | ||||
| total long term liabilities | ||||
| total liabilities | 279,553 | 284,492 | 377,709 | 350,166 |
| net assets | -279,553 | -279,553 | -275,639 | -124,995 |
| total shareholders funds | -279,553 | -279,553 | -275,639 | -124,995 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|
| Operating Activities | ||||
| Operating Profit | ||||
| Depreciation | ||||
| Amortisation | ||||
| Tax | ||||
| Stock | -162,843 | 162,843 | ||
| Debtors | -4,939 | -93,868 | 62,108 | 36,699 |
| Creditors | -4,939 | 282,890 | -1,186 | 2,788 |
| Accruals and Deferred Income | -9,897 | 80 | 9,817 | |
| Deferred Taxes & Provisions | ||||
| Cash flow from operations | ||||
| Investing Activities | ||||
| capital expenditure | ||||
| Change in Investments | ||||
| cash flow from investments | ||||
| Financing Activities | ||||
| Bank loans | ||||
| Group/Directors Accounts | -366,210 | 28,649 | 337,561 | |
| Other Short Term Loans | ||||
| Long term loans | ||||
| Hire Purchase and Lease Commitments | ||||
| other long term liabilities | ||||
| share issue | ||||
| interest | ||||
| cash flow from financing | ||||
| cash and cash equivalents | ||||
| cash | -3,263 | -22,366 | 25,629 | |
| overdraft | ||||
| change in cash | -3,263 | -22,366 | 25,629 |
orsus labs limited Credit Report and Business Information
Orsus Labs Limited Competitor Analysis
Perform a competitor analysis for orsus labs limited by selecting its closest rivals, whether from the OTHER SERVICE ACTIVITIES sector, other micro companies, companies in SW6 area or any other competitors across 12 key performance metrics.
orsus labs limited Ownership
ORSUS LABS LIMITED group structure
Orsus Labs Limited has no subsidiary companies.
Ultimate parent company
2 parents
ORSUS LABS LIMITED
12480125
orsus labs limited directors
Orsus Labs Limited currently has 2 directors. The longest serving directors include Mr Aditya Chathli (Nov 2024) and Mr Dwight Mighty (Nov 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Aditya Chathli | England | 59 years | Nov 2024 | - | Director |
| Mr Dwight Mighty | England | 64 years | Nov 2024 | - | Director |
P&L
December 2023turnover
51.2k
-29%
operating profit
0
0%
gross margin
49%
+23.91%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-279.6k
0%
total assets
0
-1%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
orsus labs limited company details
company number
12480125
Type
Private limited with Share Capital
industry
96040 - Physical well-being activities
incorporation date
February 2020
age
5
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
December 2023
previous names
voyager life limited (November 2024)
infused amphora ltd (October 2024)
accountant
-
auditor
-
address
riverbank house, 1 putney bridge approach, london, SW6 3JD
Bank
-
Legal Advisor
-
orsus labs limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to orsus labs limited.
orsus labs limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ORSUS LABS LIMITED. This can take several minutes, an email will notify you when this has completed.
orsus labs limited Companies House Filings - See Documents
| date | description | view/download |
|---|
